Common Stock, Shares, Outstanding of VYNE Therapeutics Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
VYNE Therapeutics Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • VYNE Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 33,323,171, a 125% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

VYNE Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 33,323,171 +18,493,158 +125% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q2 2025 19,773,784 +5,237,660 +36% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 15,959,488 +1,657,800 +12% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 14,830,013 +731,125 +5.2% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 14,751,433 +11,446,652 +346% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 14,536,124 +11,253,645 +343% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 14,301,688 +11,030,406 +337% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 14,098,888 +10,869,184 +337% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 3,304,781 -54,731,046 -94% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 3,282,479 -54,723,137 -94% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 3,271,282 -54,637,207 -94% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 3,229,704 +253,163 +8.5% 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q3 2022 58,035,827 +4,525,228 +8.5% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 58,005,616 +6,493,771 +13% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 57,908,489 +6,521,893 +13% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 2,976,541 -40,228,680 -93% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 53,510,599 -114,348,862 -68% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 51,511,845 -116,171,969 -69% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 51,386,596 -10,114,534 -16% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 43,205,221 +34,085,143 +374% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 167,859,461 +143,875,710 +600% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 167,683,814 +143,739,417 +600% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 61,501,130 +37,828,895 +160% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 9,120,078 -14,113,106 -61% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 23,983,751 +751,567 +3.2% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 23,944,397 +966,399 +4.2% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 23,672,235 +694,237 +3% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 23,233,184 +17,934,591 +338% 31 Dec 2018 10-K 03 Mar 2020 2019 FY
Q3 2018 23,232,184 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 22,977,998 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 22,977,998 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 5,298,593 +18,535 +0.35% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 5,280,058 31 Dec 2016 10-K 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.